Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Priyanka Khilar"'
Autor:
Priyanka Khilar, K. K. Sruthi, Sakkarai Mohamed Asha Parveen, Sirisha Natani, Surender Singh Jadav, Ramesh Ummanni
Publikováno v:
Journal of Cell Communication and Signaling.
Autor:
Sakkarai Mohamed Asha Parveen, Sirisha Natani, null Sruthi K.K., Priyanka Khilar, Ramesh Ummanni
Publikováno v:
The international journal of biochemistrycell biology. 147
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is overexpressed in prostate cancer (PCa) and promotes PCa progression in in vivo through the ADMA-NO pathway by degrading nitric oxide synthase (NOS) inhibitors such as asymmetric dimethylarginine (A
Autor:
Sirisha, Natani, K K, Sruthi, Sakkarai Mohamed, Asha, Priyanka, Khilar, Pampana Sandhya Venkata, Lakshmi, Ramesh, Ummanni
Publikováno v:
Cellular Signalling. 91:110240
Neuroendocrine prostate cancer (NEPC) is an aggressive, androgen independent PCa and it is detected in patients undergoing androgen deprivation therapy (ADT). Interleukin-6 (IL-6) is a pleiotropic cytokine elevated in PCa patients promotes neuroendoc
Autor:
K.K. Sruthi, Asha Parveen, Ramesh Ummanni, Sirisha Natani, Supriya Bhukya, Priyanka Khilar, Vishnu M. Dhople
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868:119085
Neuroendocrine Prostate Cancer (NEPC) is an aggressive form of androgen independent prostate cancer (AIPC), correlated with therapeutic resistance. Interleukin (IL)-6 promotes proliferation and neuroendocrine differentiation (NED) of androgen depende